[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
[ Tue, Aug 13th 2024 ]: WOPRAI
Matt O"Brien Maintained (TELA) at Buy with Decreased Target to $8 on, Aug 13th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Matt O"Brien of Piper Sandler, Maintained "TELA Bio, Inc." (TELA) at Buy with Decreased Target from $10 to $8 on, Aug 13th, 2024.
Matt, nor any peers, have made any analyst calls on TELA in the last 4 months.